💉 Sanofi-AZ make more headway in RSV; GSK to make cancer antibodies with WuXi

#249 | Finally, we get a chance to sting bees

Hello, and welcome back to The Kable for the last day of what has been quite an eventful week.

One observation we have to make about this week is that all manners of companies, big and small, have decided this is the week when they will replenish their pipelines or stock up their R & D budgets. Like GSK, who’s just inked a megadeal worth up to $1.5 billi…